Michelino De Laurentiis
Michelino De Laurentiis
IST.Tumori Napoli "Fondazione Pascale", Napoli, ITALY
Verifierad e-postadress på istitutotumori.na.it
Titel
Citeras av
Citeras av
År
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 365 (9472), 1687-1717, 2005
58142005
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 366 (9503), 2087-2106, 2005
47832005
Tamoxifen for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 351 (9114), 1451-1467, 1998
31851998
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer
A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, JF Forbes, ...
Lancet 365 (9453), 60-62, 2005
22852005
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 …
Early Breast Cancer Trialists' Collaborative Group
The Lancet 378 (9804), 1707-1716, 2011
22292011
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
EBCTC Group
The lancet 378 (9793), 771-784, 2011
1892*2011
Polychemotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 352 (9132), 930-942, 1998
18291998
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC …
A The
The Lancet 359 (9324), 2131-2139, 2002
15962002
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
EBCTC Group
The Lancet 379 (9814), 432-444, 2012
1410*2012
Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 355 (9217), 1757-1770, 2000
10002000
Palbociclib in hormone-receptor–positive advanced breast cancer
NC Turner, J Ro, F André, S Loi, S Verma, H Iwata, N Harbeck, S Loibl, ...
New England Journal of Medicine 373 (3), 209-219, 2015
9802015
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer
Early Breast Cancer Trialists' Collaborative Group
New England journal of medicine 319 (26), 1681-1692, 1988
8191988
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer: results of the ATAC …
ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group
Cancer 98 (9), 1802-1810, 2003
7112003
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 386 (10001), 1341-1352, 2015
5692015
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.
C Carlomagno, F Perrone, C Gallo, M De Laurentiis, R Lauria, A Morabito, ...
Journal of Clinical Oncology 14 (10), 2702-2708, 1996
5301996
Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer
G Di Lorenzo, G Tortora, FP D’Armiento, G De Rosa, S Staibano, ...
Clinical Cancer Research 8 (11), 3438-3444, 2002
5162002
Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials
M De Laurentiis, G Cancello, D D'Agostino, M Giuliano, A Giordano, ...
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2008
4462008
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study
G Fontanini, S Vignati, F Basolo, G Bevilacqua, M Lucchi, A Mussi, ...
Journal of the National Cancer Institute 89 (12), 881-886, 1997
3781997
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer
M De Laurentiis, G Arpino, E Massarelli, A Ruggiero, C Carlomagno, ...
Clinical cancer research 11 (13), 4741-4748, 2005
3702005
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin …
G Fontanini, M De Laurentiis, S Vignati, S Chinè, M Lucchi, V Silvestri, ...
Clinical Cancer Research 4 (1), 241-249, 1998
3561998
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20